| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |